Douglas G. Ward

4.2k total citations
106 papers, 2.5k citations indexed

About

Douglas G. Ward is a scholar working on Molecular Biology, Surgery and Spectroscopy. According to data from OpenAlex, Douglas G. Ward has authored 106 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 38 papers in Surgery and 19 papers in Spectroscopy. Recurrent topics in Douglas G. Ward's work include Bladder and Urothelial Cancer Treatments (31 papers), Advanced Proteomics Techniques and Applications (17 papers) and Urinary and Genital Oncology Studies (17 papers). Douglas G. Ward is often cited by papers focused on Bladder and Urothelial Cancer Treatments (31 papers), Advanced Proteomics Techniques and Applications (17 papers) and Urinary and Genital Oncology Studies (17 papers). Douglas G. Ward collaborates with scholars based in United Kingdom, Netherlands and United States. Douglas G. Ward's co-authors include Richard T. Bryan, Wenbin Wei, Philip J. Johnson, A Martin, Nicholas D. James, Maurice P. Zeegers, Tariq Ismail, Kar Keung Cheng, Ian P. Trayer and Michael J.O. Wakelam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Douglas G. Ward

101 papers receiving 2.5k citations

Peers

Douglas G. Ward
Peter Riegman Netherlands
Scott P. Henry United States
Andrew C. Pearce United Kingdom
Jürgen Römisch Germany
Rosie Z. Yu United States
Kazufumi Honda Japan
Shunsuke Furuta Japan
Mehdi Mesri United States
Chan-Sik Park South Korea
Joseph R. Slupsky United Kingdom
Peter Riegman Netherlands
Douglas G. Ward
Citations per year, relative to Douglas G. Ward Douglas G. Ward (= 1×) peers Peter Riegman

Countries citing papers authored by Douglas G. Ward

Since Specialization
Citations

This map shows the geographic impact of Douglas G. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas G. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas G. Ward more than expected).

Fields of papers citing papers by Douglas G. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas G. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas G. Ward. The network helps show where Douglas G. Ward may publish in the future.

Co-authorship network of co-authors of Douglas G. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas G. Ward. A scholar is included among the top collaborators of Douglas G. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas G. Ward. Douglas G. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ward, Douglas G., Richard T. Bryan, Aadel A. Chaudhuri, et al.. (2025). Unlocking the potential of urine-based liquid biopsy through improved reporting and standardization. Nature reviews. Cancer. 26(2). 79–80.
2.
3.
Goel, Anshita, Naheema S. Gordon, Kar Keung Cheng, et al.. (2025). Circulating Tumour DNA Positivity Predicts Shorter Survival for Patients with High-grade pT1 Urothelial Bladder Carcinoma. European Urology. 89(4). 381–383.
4.
Türker, Polat, Per‐Uno Malmström, Artur Mezheyeuski, et al.. (2023). Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer. BMC Cancer. 23(1). 605–605. 7 indexed citations
5.
Ward, Douglas G., et al.. (2021). The Sirenic Links between Diabetes, Obesity, and Bladder Cancer. International Journal of Molecular Sciences. 22(20). 11150–11150. 23 indexed citations
6.
Bryan, Richard T., Roland Arnold, Farhat L. Khanim, et al.. (2021). Establishing the Bladder Cancer Research Centre at the University of Birmingham. Nature Reviews Urology. 18(6). 318–320. 1 indexed citations
7.
Gurung, Pratik, Jayne S. Wilson, John Hudson, et al.. (2019). Prognostic DNA Methylation Biomarkers in High-risk Non–muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation. European Urology Focus. 6(4). 683–697. 9 indexed citations
8.
Iqbal, Mohammad S., et al.. (2018). Structural investigation of hemicelluloses from Plantago ovata, Mimosa pudica and Lallemantia royleana by MALDI-ToF mass spectrometry. Journal of Carbohydrate Chemistry. 37(5). 285–301. 7 indexed citations
9.
10.
Reed, Michelle A.C., Christian Ludwig, Douglas G. Ward, et al.. (2017). Metabolomic Evidence for a Field Effect in Histologically Normal and Metaplastic Tissues in Patients with Esophageal Adenocarcinoma. Neoplasia. 19(3). 165–174. 15 indexed citations
11.
Ward, Douglas G., Laura Baxter, Naheema S. Gordon, et al.. (2016). Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer. PLoS ONE. 11(2). e0149756–e0149756. 59 indexed citations
12.
Rampton, David S., James Goodhand, N Joshi, et al.. (2016). Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial. Journal of Crohn s and Colitis. 11(6). jjw208–jjw208. 15 indexed citations
13.
D'Costa, Jamie, et al.. (2016). A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer. Bladder Cancer. 2(3). 301–317. 76 indexed citations
14.
Messer, Andrew E., Mohammed El‐Mezgueldi, Charles Redwood, et al.. (2016). Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation. Archives of Biochemistry and Biophysics. 601. 113–120. 50 indexed citations
15.
Noy, Peter J., Kabir A. Khan, Xiaodong Zhuang, et al.. (2015). Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth. Oncogene. 34(47). 5821–5831. 43 indexed citations
16.
Hitchen, Paul G., et al.. (2012). Z-band Alternatively Spliced PDZ Motif Protein (ZASP) Is the Major O-Linked β-N-Acetylglucosamine-substituted Protein in Human Heart Myofibrils. Journal of Biological Chemistry. 288(7). 4891–4898. 11 indexed citations
17.
Finkenstedt, Armin, Andreas Widschwendter, Carole Brasse‐Lagnel, et al.. (2012). Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy. Blood Cells Molecules and Diseases. 48(4). 233–237. 35 indexed citations
18.
Iqbal, Tariq, Douglas G. Ward, Matthew Brookes, et al.. (2009). Is iron overload in alcohol-related cirrhosis mediated byhepcidin?. World Journal of Gastroenterology. 15(46). 5864–5864. 12 indexed citations
19.
Ward, Douglas G., Michael P. Cornes, & Ian P. Trayer. (2002). Structural Consequences of Cardiac Troponin I Phosphorylation. Journal of Biological Chemistry. 277(44). 41795–41801. 29 indexed citations
20.
Roussel, A. J. & Douglas G. Ward. (1985). Ruptured urinary bladder in a heifer. Journal of the American Veterinary Medical Association. 186(12). 1310–1311. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Riegman Breakdown of academic impact, for papers by Scott P. Henry Breakdown of academic impact, for papers by Andrew C. Pearce Breakdown of academic impact, for papers by Jürgen Römisch Breakdown of academic impact, for papers by Rosie Z. Yu Breakdown of academic impact, for papers by Kazufumi Honda Breakdown of academic impact, for papers by Shunsuke Furuta Breakdown of academic impact, for papers by Mehdi Mesri Breakdown of academic impact, for papers by Chan-Sik Park Breakdown of academic impact, for papers by Joseph R. Slupsky
Rankless by CCL
2026